Monday, November 06, 2023
Corewell 黄色仓库™ is pleased to welcome M.D., MBA, as the new chief of cardiovascular surgery for Corewell 黄色仓库 in Southeast Michigan.
“We are proud and honored to give Dr. Schwann a warm welcome to our celebrated and nationally ranked cardiac surgery program,” said Penny Wilton, M.D., physician executive for cardiovascular services.
Dr. Schwann earned his undergraduate and medical degrees at Columbia University and completed his postgraduate training in general surgery and cardiac surgery at the Yale-New Haven Medical Center. He has held increasingly prominent academic and clinical leadership positions at various institutions in the Midwest and Northeast.
“I am honored to have the privilege to lead the cardiovascular surgery team at Corewell 黄色仓库 in Southeast Michigan,” Dr. Schwann said. “They have done phenomenal work and are rooted in a long history of excellence. As a servant leader, I am very much looking forward to working beside so many dedicated and renowned physicians, nurses and staff who work collaboratively to enhance patient-centered care. I look forward to finding innovative approaches to cardiovascular pathology which regrettably remains the principal cause of mortality in the United States.”
Dr. Schwann joined the faculty of the University of Toledo College of Medicine as the chief of cardiothoracic surgery in 2009, earning his Master of Business Administration in 2012. In addition to a busy clinical practice, he served as chief of staff and associate dean of graduate medical education.
Since 2018, Dr. Schwann has served as chief of cardiothoracic surgery at the University of Massachusetts Chan School of Medicine – Baystate and associate medical director of the Baystate Heart and Vascular Service, where he succeeded in significantly expanding the size and scope of its program.
Dr. Schwann has published over 100 peer-reviewed publications in prestigious medical journals in the areas of multiple arterial coronary artery bypass, optimal blood management strategies, and management of valvular heart disease and atrial fibrillation.